Molecular Partners AG
MLLCF
$4.22
-$0.06-1.40%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -72.63% | 271.50% | -4.99% | -58.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -72.63% | 271.50% | -4.99% | -58.39% |
| Cost of Revenue | -20.01% | -4.42% | 11.84% | 17.58% | 14.01% |
| Gross Profit | 12.42% | -14.69% | -2.23% | -24.72% | -36.54% |
| SG&A Expenses | -6.60% | 1.72% | -5.41% | -12.66% | -0.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.63% | -2.73% | 6.90% | 8.51% | 8.88% |
| Operating Income | 10.40% | -10.44% | 0.01% | -11.24% | -21.01% |
| Income Before Tax | 42.75% | -46.43% | 6.22% | 18.89% | -23.36% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 42.74% | -46.43% | 6.22% | 18.89% | -23.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.74% | -46.43% | 6.22% | 18.89% | -23.36% |
| EBIT | 10.40% | -10.44% | 0.01% | -11.24% | -21.01% |
| EBITDA | 10.65% | -10.93% | -0.02% | -11.50% | -21.12% |
| EPS Basic | 48.99% | -44.88% | 7.22% | 19.65% | -22.20% |
| Normalized Basic EPS | 49.00% | -44.87% | 7.24% | 19.67% | -22.17% |
| EPS Diluted | 48.68% | -44.88% | 7.22% | 19.65% | -22.20% |
| Normalized Diluted EPS | 49.00% | -44.87% | 7.24% | 19.67% | -22.17% |
| Average Basic Shares Outstanding | 12.26% | 1.09% | 1.07% | 0.96% | 0.95% |
| Average Diluted Shares Outstanding | 12.26% | 1.09% | 1.07% | 0.96% | 0.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |